Mystic Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-150
Closed -$25K 212
2021
Q4
$25K Buy
+150
New +$22.8K 0.01% 305

Other funds holding DGX

Mystic Asset Management's DGX Position: Q1 2022 in Review

Mystic Asset Management sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 150 shares — an estimated $25K sold.

Mystic Asset Management first reported a position in DGX in Q4 2021 and held it in 1 quarter. The position peaked at $25K in Q4 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

  • Mystic Asset Management reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
  • Mystic Asset Management sold 150 Quest Diagnostics shares in Q1 2022, an estimated $25K.
  • Mystic Asset Management first reported a position in Quest Diagnostics in Q4 2021 and held it in 1 quarter.
  • Mystic Asset Management's Quest Diagnostics position peaked at $25K in Q4 2021.
  • 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on Mystic Asset Management's 13F filing for Q1 2022, filed 11 May 2022.